Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anshen Bunao Liquid is a traditional Chinese patent medicine (TCM) formulated to treat neurasthenia, insomnia, dizziness, fatigue, and amnesia caused by kidney essence deficiency and qi-blood insufficiency. It is a multi-herb botanical compound preparation containing Herba Epimedii, Radix Polygoni Multiflori Preparata, Rhizoma Zingiberis, Radix Glycyrrhizae, Fructus Jujubae, Cornu Cervi Pantotrichum, and Vitamin B6. The formulation acts through a network of multiple components, targets, and pathways. Recent research suggests it also exerts anxiolytic effects by modulating neuroinflammation, maintaining intestinal barrier integrity, and regulating gut microbiota.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Anshen Bunao Liquid.